美国 · SEC FORM 4
Parabilis Medicines, Inc.
PBLS · Nasdaq · CIK 0001657677 · Healthcare · Biotechnology
内部人信号
72.2 / 100
3 位买方 · 14 条买入交易行 · $441.4M 买入总额
为什么有这个信号？
买方广度中等
买入规模较强
角色中等
近期性较低
确信度较强
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
Cluster+21.0 / 35
买入规模+24.9 / 25
角色+14.0 / 20
近期性+2.3 / 10
确信度+10.0 / 10
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.Director; Director,TenPercentOwner
○●●●●
SEBULSKY ALANDirector
●●●
Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLCTenPercentOwner
○●
FITZGERALD EDWARD MDirector
○
Borisy AlexisDirector
○
DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James ETenPercentOwner,Other
○
● 买入▼ 卖出○ 其他
—
买方广度与集中度
合资格买方3
买入集中度98%最大买方： Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. · $430.7M
聚集买入 · 15天3 insiders峰值活动： 2026-06-11–2026-06-15
Roles in the peak window: Director, Director; Director,TenPercentOwner, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
72.2 / 100
最新留档分数
↓ -0.1 pts相对上一个留档快照
- 72.4
- 72.4
- 72.4
- 72.3
- 72.2
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
14买入
0卖出
11其他 Form 4 交易行
8SEC 申报 · 365天
买入14 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他11 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -24.3%
- 3M
- -7.3%
- 6M
- —
- 12M
- —
波动率与流动性
- 波动率
- 69.6%
- Beta
- —
- 平均每日成交额
- USD 19.2M
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 8,261,483
- 上期报告
- 6,092,212
- 日均成交量
- 1,707,144
- 回补天数
- 4.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC 申报 ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC 申报 ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC 申报 ↗ |
| 2026-06-15 | SEBULSKY ALAN | 买入 (P) | Common Stock | 9,065 | USD 26.49 | USD 240,162 | SEC 申报 ↗ |
| 2026-06-12 | SEBULSKY ALAN | 买入 (P) | Common Stock | 8,435 | USD 27.67 | USD 233,396 | SEC 申报 ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | 买入 (P) | Common Stock, par value $0.0001 per share | 500,000 | USD 20.00 | USD 10,000,000 | SEC 申报 ↗ |
| 2026-06-11 | SEBULSKY ALAN | 买入 (P) | Common Stock | 12,500 | USD 20.00 | USD 250,000 | SEC 申报 ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 21,188,750 | USD 20.00 | USD 423,775,000 | SEC 申报 ↗ |
Form 4 申报证据
25 transaction lines in the latest 365-day window; 25 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC 申报 ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC 申报 ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC 申报 ↗ |
展开近期 Form 4 证据 (13 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC 申报 ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC 申报 ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC 申报 ↗ |
| 2026-06-15 | SEBULSKY ALAN | 买入 (P) | Common Stock | 9,065 | USD 26.49 | USD 240,162 | SEC 申报 ↗ |
| 2026-06-12 | SEBULSKY ALAN | 买入 (P) | Common Stock | 8,435 | USD 27.67 | USD 233,396 | SEC 申报 ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | 买入 (P) | Common Stock, par value $0.0001 per share | 500,000 | USD 20.00 | USD 10,000,000 | SEC 申报 ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | C (C) | Common Stock, par value $0.0001 per share | 527,070 | USD 9.48 | USD 4,996,624 | SEC 申报 ↗ |
| 2026-06-11 | SEBULSKY ALAN | 买入 (P) | Common Stock | 12,500 | USD 20.00 | USD 250,000 | SEC 申报 ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | 买入 (P) | Voting Common Stock | 21,188,750 | USD 20.00 | USD 423,775,000 | SEC 申报 ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | C (C) | Voting Common Stock | 7,744,621 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-11 | FITZGERALD EDWARD M | C (C) | Common Stock | 14,688 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-11 | Borisy Alexis | C (C) | Common Stock | 105,414 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E | C (C) | Voting Common Stock | 940,352 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PBLS |
| CIK | 0001657677 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 25 transaction lines from 2026-06-11 to 2026-07-22 14 P purchase lines · 0 S sale lines · 11 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.